105 related articles for article (PubMed ID: 35666447)
21. Engineering activatable promoters for scalable and multi-input CRISPRa/i circuits.
Alba Burbano D; Cardiff RAL; Tickman BI; Kiattisewee C; Maranas CJ; Zalatan JG; Carothers JM
Proc Natl Acad Sci U S A; 2023 Jul; 120(30):e2220358120. PubMed ID: 37463216
[TBL] [Abstract][Full Text] [Related]
22. CRISPR activation and interference as investigative tools in the cardiovascular system.
Carroll MS; Giacca M
Int J Biochem Cell Biol; 2023 Feb; 155():106348. PubMed ID: 36563996
[TBL] [Abstract][Full Text] [Related]
23. CRISPRactivation-SMS, a message for PAM sequence independent gene up-regulation in Escherichia coli.
Klanschnig M; Cserjan-Puschmann M; Striedner G; Grabherr R
Nucleic Acids Res; 2022 Oct; 50(18):10772-10784. PubMed ID: 36134715
[TBL] [Abstract][Full Text] [Related]
24. Off-target effects of CRISPRa on interleukin-6 expression.
Soubeyrand S; Lau P; Peters V; McPherson R
PLoS One; 2019; 14(10):e0224113. PubMed ID: 31658298
[TBL] [Abstract][Full Text] [Related]
25. Quantification of Genome Editing and Transcriptional Control Capabilities Reveals Hierarchies among Diverse CRISPR/Cas Systems in Human Cells.
Escobar M; Li J; Patel A; Liu S; Xu Q; Hilton IB
ACS Synth Biol; 2022 Oct; 11(10):3239-3250. PubMed ID: 36162812
[TBL] [Abstract][Full Text] [Related]
26. Bidirectional manipulation of gene expression in adipocytes using CRISPRa and siRNA.
Lundh M; Pluciñska K; Isidor MS; Petersen PSS; Emanuelli B
Mol Metab; 2017 Oct; 6(10):1313-1320. PubMed ID: 29031730
[TBL] [Abstract][Full Text] [Related]
27. High-throughput screen reveals sRNAs regulating crRNA biogenesis by targeting CRISPR leader to repress Rho termination.
Lin P; Pu Q; Wu Q; Zhou C; Wang B; Schettler J; Wang Z; Qin S; Gao P; Li R; Li G; Cheng Z; Lan L; Jiang J; Wu M
Nat Commun; 2019 Aug; 10(1):3728. PubMed ID: 31427601
[TBL] [Abstract][Full Text] [Related]
28. Next-generation CRISPR/Cas9 transcriptional activation in
Jia Y; Xu RG; Ren X; Ewen-Campen B; Rajakumar R; Zirin J; Yang-Zhou D; Zhu R; Wang F; Mao D; Peng P; Qiao HH; Wang X; Liu LP; Xu B; Ji JY; Liu Q; Sun J; Perrimon N; Ni JQ
Proc Natl Acad Sci U S A; 2018 May; 115(18):4719-4724. PubMed ID: 29666231
[TBL] [Abstract][Full Text] [Related]
29. CRISPR/dCas-mediated gene activation toolkit development and its application for parthenogenesis induction in maize.
Qi X; Gao H; Lv R; Mao W; Zhu J; Liu C; Mao L; Li X; Xie C
Plant Commun; 2023 Mar; 4(2):100449. PubMed ID: 36089769
[TBL] [Abstract][Full Text] [Related]
30. CRISPR-Cas RNA Scaffolds for Transcriptional Programming in Yeast.
Zalatan JG
Methods Mol Biol; 2017; 1632():341-357. PubMed ID: 28730450
[TBL] [Abstract][Full Text] [Related]
31. New CRISPR-Cas systems from uncultivated microbes.
Burstein D; Harrington LB; Strutt SC; Probst AJ; Anantharaman K; Thomas BC; Doudna JA; Banfield JF
Nature; 2017 Feb; 542(7640):237-241. PubMed ID: 28005056
[TBL] [Abstract][Full Text] [Related]
32. Highly efficient and specific regulation of gene expression using enhanced CRISPR-Cas12f system.
Oh Y; Gwon LW; Lee HK; Hur JK; Park KH; Kim KP; Lee SH
Gene Ther; 2024 Jun; ():. PubMed ID: 38918512
[TBL] [Abstract][Full Text] [Related]
33. Awakening dormant glycosyltransferases in CHO cells with CRISPRa.
Karottki KJC; Hefzi H; Xiong K; Shamie I; Hansen AH; Li S; Pedersen LE; Li S; Lee JS; Lee GM; Kildegaard HF; Lewis NE
Biotechnol Bioeng; 2020 Feb; 117(2):593-598. PubMed ID: 31631317
[TBL] [Abstract][Full Text] [Related]
34. Optimized strategy for in vivo Cas9-activation in
Ewen-Campen B; Yang-Zhou D; Fernandes VR; González DP; Liu LP; Tao R; Ren X; Sun J; Hu Y; Zirin J; Mohr SE; Ni JQ; Perrimon N
Proc Natl Acad Sci U S A; 2017 Aug; 114(35):9409-9414. PubMed ID: 28808002
[TBL] [Abstract][Full Text] [Related]
35. General guidelines for CRISPR/Cas-based genome editing in plants.
Aksoy E; Yildirim K; Kavas M; Kayihan C; Yerlikaya BA; Çalik I; Sevgen İ; Demirel U
Mol Biol Rep; 2022 Dec; 49(12):12151-12164. PubMed ID: 36107373
[TBL] [Abstract][Full Text] [Related]
36. CRISPR-Enabled Tools for Engineering Microbial Genomes and Phenotypes.
Tarasava K; Oh EJ; Eckert CA; Gill RT
Biotechnol J; 2018 Sep; 13(9):e1700586. PubMed ID: 29917318
[TBL] [Abstract][Full Text] [Related]
37. The Cas6e ribonuclease is not required for interference and adaptation by the E. coli type I-E CRISPR-Cas system.
Semenova E; Kuznedelov K; Datsenko KA; Boudry PM; Savitskaya EE; Medvedeva S; Beloglazova N; Logacheva M; Yakunin AF; Severinov K
Nucleic Acids Res; 2015 Jul; 43(12):6049-61. PubMed ID: 26013814
[TBL] [Abstract][Full Text] [Related]
38. Multiplexed CRISPR Activation of Cryptic Sugar Metabolism Enables Yarrowia Lipolytica Growth on Cellobiose.
Schwartz C; Curtis N; Löbs AK; Wheeldon I
Biotechnol J; 2018 Sep; 13(9):e1700584. PubMed ID: 29729131
[TBL] [Abstract][Full Text] [Related]
39. Programmable Gene Knockdown in Diverse Bacteria Using Mobile-CRISPRi.
Banta AB; Ward RD; Tran JS; Bacon EE; Peters JM
Curr Protoc Microbiol; 2020 Dec; 59(1):e130. PubMed ID: 33332762
[TBL] [Abstract][Full Text] [Related]
40. CRISPR-Cas system in microbial hosts for terpenoid production.
Chu LL
Crit Rev Biotechnol; 2022 Nov; 42(7):1116-1133. PubMed ID: 35139706
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
